Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05479812 |
| Title | Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Werewolf Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| HonorHealth | Scottsdale | Arizona | 85258 | United States | Details | |
| Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| Emory Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
| Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| Minnesota Oncology Hematology, P.A. | Maple Grove | Minnesota | 55369 | United States | Details | |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
| Roswell Park Comprehensive Cancer Care | Buffalo | New York | 14203 | United States | Details | |
| Westchester Medical Center | Hawthorne | New York | 10532 | United States | Details | |
| Providence Cancer Institute Franz Clinic | Portland | Oregon | 97213 | United States | Details | |
| Texas Oncology - Austin Midtown | Austin | Texas | 78705-1165 | United States | Details | |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-8852 | United States | Details | |
| NEXT Oncology | Houston | Texas | 77054 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details |